Syngene International: Slow Growth, Rich Valuation
Moneylife Digital Team 12 May 2022
The discovery and development of new medicines is a highly complex and R&D (research & development)-intensive process. From drug discovery through to FDA (Food and Drug Administration) approval, developing a new medicine takes, on average, 10 to 15 years and costs US$2.6bn (billion). For every 5,000-10,000 compounds that enter the R&D pipeline, ultimately, only one receives approval. Less than...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
IPO Review: Venus Pipes and Tubes Ltd
Moneylife Digital Team 12 May 2022
Incorporated in 2015, the sole focus of Venus Pipes and Tubes Ltd (Venus) is on manufacturing welded and seamless pipes in a single metal category of stainless steel (SS). It has five production lines at its manufacturing facility...
CG Power and Industrial Solutions Limited: March ’22 Update
Moneylife Digital Team 12 May 2022
In the first full financial year results since Murugappa group started running CG Power and Industrial Solutions (CGPI), the company has made a complete turnaround. However, results for Q4FY21-22 were lacklustre as input cost...
IPO Review: Delhivery Ltd
Moneylife Digital Team 11 May 2022
Incorporated in 2011, Delhivery Ltd (DL) is India’s largest and fastest growing fully-integrated logistics services-provider (LSP) in India by revenue as of FY20-21. It provides a full range of logistics services, including express...
Privi Speciality Chemicals: March ’22 Results Update
Moneylife Digital Team 11 May 2022
In Q4FY21-22, Privi Speciality Chemicals (Privi) reported a revenue growth of 7% y-o-y (year-on-year), while sequentially revenue declined by 4% to Rs 377 crore. The growth has been on account of increase in price realisation. There...
Free Helpline
Legal Credit
Feedback